Bailrigg Diagnostics


Bailrigg Diagnostics Limited is dedicated to advancing medical diagnostics through innovative, portable, and rapid testing technology. Their platform combines microfluidic processes, sensors, and wireless data transmission to provide near-patient results, aiming to improve clinical care and empower patients and doctors. They focus on sports medicine and critical care diagnostics, with a vision to revolutionize how test results are obtained and used in healthcare.

Industries

biotechnology
medical
medical-device

Nr. of Employees

small (1-50)

Bailrigg Diagnostics


Products

Bedside blood analysis system (test cartridge + handheld reader)

A two-component point-of-care diagnostic system comprising a disposable test cartridge with integrated biosensors and a handheld reader that interprets signals, returns quantitative results within minutes, and supports data processing and wireless transmission.

Sports medicine blood lactate device (panel development)

Device configuration and assay panel focused on measuring blood lactate and related analytes to evaluate athletic performance and guide training regimens.


Services

Development of software for management algorithms, result trending, and wireless exchange of results with mobile apps and electronic medical records.

Expertise Areas

  • Point-of-care diagnostics
  • Biosensor development
  • Microfluidics
  • Digital health and EMR integration
  • Show More (4)

Key Technologies

  • Microfluidics
  • Electrochemical biosensors
  • Immunoassays
  • Handheld diagnostic reader hardware
  • Show More (4)

News & Updates

Come and visit us at the leading international medical trade fair between 18th-21st November 2019. Stand Number: K03-3 Location: Hall 16

This lists our project “Bedside Diagnostics” as one of five examples of notable success supported through Impact Acceleration Account (IAA) under EPSRC.

Discussion about being shortlisted as a finalist at the 2017 MIT Technology Review’s ‘Innovators Under 35 Europe’ awards.

Discussing how our technology is going to change how the NHS treats patients in the future.

Patent number: GB1811279.7, granted by the UK Intellectual Property Office in 2019. PCT application filed in 2018.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.